Med tech companies live or die based on approvals by the FDA. Hosts John MacMahon and Sandy Miller relate from their own experiences how previous FDA management was hard to predict and decisions often seemed erratic. This led to many companies moving their testing to Europe enabling Europe to bring new medical technologies to patients much sooner than the US. But a more effective, better informed FDA has reversed this trend and the United States has risen to the top for medical device testing and treating of patients.

Email us at [email protected] or call us at 855-283-4666.

Visit: bwdpod.com

Twitter: @bwdpodcast

Linked In: Before We Die Podcast

Check out other shows from Offscrip Health

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.